This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letter to the Editor

Once-Daily Venlafaxine XR Compared With Fluoxetine in Outpatients With Depression and Anxiety

Rajinder Judge and Brian E. Wagner

Published: November 30, 1999

Article Abstract

Letter to the Editor

Sir: We read with interest the study conducted by Silverstone et al. which reaffirms the efficacy of fluoxetine in patients with anxiety and depression. However, the authors’ statement in the abstract claiming that this study "provides evidence for [venlafaxine XR’s ] superiority over fluoxetine" is unfounded and may mislead readers who have not had the opportunity to critically review the article. A thorough review of this study plainly demonstrates that fluoxetine has comparable efficacy to venlafaxine XR and better tolerability.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 60

Quick Links: